Dublin, Nov. 15, 2019 (GLOBE NEWSWIRE) -- The "Microtome Market by Product (Instruments, (Rotary, Cryostat), Accessories), Application (Disease Diagnosis, Medical Research), Technology (Manual, Semi-automated, Fully Automated), End User (Hospital, Clinical Laboratories) - Global Forecast to 2024" report has been added to ResearchAndMarkets.com's offering.
The global microtomes market is expected to reach USD 177.1 million by 2024 from USD 129.1 million in 2019, at a CAGR of 6.5%.
In 2018, Thermo Fisher Scientific (US), Danaher Corporation (US), and Sakura Finetek (Japan) dominated the microtomes market. Other prominent players in this market include SLEE Medical GmbH (Germany), MEDITE GmbH (Germany), Histo-Line Laboratories (Italy), Amos Scientific (Australia), RMC Boeckeler, Diapath S.p.A. (Italy), and Jinhua YIDI Medical Appliance (China).
High prevalence of cancer, growing demand for digital pathology, and increasing healthcare expenditure are expected to drive the overall growth of the microtomes market
This market is experiencing significant growth due to the growing demand for digital pathology, high prevalence of cancer, and increasing healthcare expenditure. Also, the increasing focus on personalized medicine and the emerging economies are offering growth opportunities for players in the microtomes market. However, a lack of skilled professionals to operate microtomes is expected to restrain the growth of this market during the forecast period.
Disease diagnosis is expected to dominate the market during the forecast period.
Based on application, the microtomes market is segmented into disease diagnosis and medical research. Disease diagnosis accounted for the larger market share in 2018, as compared to other segments. Growth in the geriatric population and the increasing incidences of cancer and other chronic diseases are the factors contributing to the larger market share.
Hospital laboratories to witness the highest growth in microtomes market, by the end-user, in 2018
Based on end-user, the microtomes market is segmented into clinical laboratories, hospital laboratories, and other end users. The hospital laboratories segment accounted for the largest market share in 2018 as well as the highest CAGR during the forecast period. The large share and the highest growth of the hospital laboratories segment are attributed to the increasing number of patient visits to hospitals, rising number of in-house clinical diagnostic procedures performed in hospitals, growing awareness regarding early diagnosis, and the availability of reimbursements in developed markets for clinical tests performed in hospitals.
North America to dominate the market during the forecast period
Geographically, the microtomes market is segmented into North America, Europe, the Asia Pacific, and Rest of the World. In 2018, North America accounted for the largest share of the microtomes market. Growing opportunities for advanced cancer diagnostic testing and screening, the easy accessibility to advanced technologies, favorable reimbursement scenario for anatomic pathology diagnostic tests, increasing healthcare expenditure, and the presence of high-quality infrastructure for hospitals and clinical laboratories in the region are the major factors driving the growth of the microtomes market in North America.
Key Topics Covered
1 Introduction
2 Research Methodology
3 Executive Summary
4 Premium Insights
4.1 Microtomes: Market Overview
4.2 Asia Pacific: Microtomes Market Share, By End User and Country (2019)
4.3 Microtomes Market, By Technology (USD Million)
4.4 Microtomes Market, By Application, 2019 vs. 2024 (USD Million)
4.5 Microtomes Market, By Product, 2019 vs. 2024 (USD Million)
4.6 Geographical Snapshot of the Microtomes Market
5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Market Drivers
5.2.1.1 High Prevalence of Cancer
5.2.1.2 Growing Demand for Digital Pathology
5.2.1.3 Increasing Healthcare Expenditure
5.2.2 Market Restraints
5.2.2.1 Lack of Skilled Professionals
5.2.3 Market Opportunities
5.2.3.1 Growing Focus on Personalized Medicine
5.2.3.2 Emerging Economies
6 Microtomes Market, By Product
6.1 Introduction
6.2 Microtome Instruments
6.2.1 Rotary Microtomes
6.2.1.1 Rotary Microtomes are the Most Common Types of Microtomes Used in Histology Laboratories
6.2.2 Cryostat Microtomes
6.2.2.1 Cryostat Microtomes Provide Immediate Results By Quickly, Reliably, and Safely Cutting Accurate Frozen Sections
6.2.3 Vibrating Microtomes
6.2.3.1 Vibrating Microtomes are Designed to Cut Fresh Tissue Specimens
6.2.4 Other Microtomes
6.3 Microtome Accessories
6.3.1 The Adoption of Disposable Blades has Increased as they Help in Producing High-Quality Sections
7 Microtomes Market, By Application
7.1 Introduction
7.2 Disease Diagnosis
7.2.1 High Prevalence of Cancer to Drive Market Growth
7.3 Medical Research
7.3.1 Increasing Research Activities to Drive the Adoption of Microtomes
8 Microtomes Market, By Technology
8.1 Introduction
8.2 Manual Microtomes
8.2.1 Lower Cost and User Comfort Associated With these Microtomes are Driving their Adoption
8.3 Semi-Automated Microtomes
8.3.1 Semi-Automated Microtomes to Register the Highest Growth Rate During the Forecast Period
8.4 Fully Automated Microtomes
8.4.1 Lack of Clinical Laboratory Technicians and the High Prevalence of Cancer Have Resulted in the Increased Adoption of Fully Automated Microtomes
9 Microtomes Market, By End User
9.1 Introduction
9.2 Hospital Laboratories
9.2.1 Hospital Laboratories Accounted for the Largest Share of the Market, By End User
9.3 Clinical Laboratories
9.3.1 Presence of Robust Infrastructure to Perform Tests in High Volumes is Estimated to Drive Market Growth
9.4 Other End Users
10 Microtomes Market, By Region
10.1 Introduction
10.2 North America
10.2.1 US
10.2.1.1 High Burden of Cancer and Numerous Conferences on Anatomic Pathology to Drive Market Growth
10.2.2 Canada
10.2.2.1 Availability of Research Funding & Rising Incidence of Cancer to Drive Market Growth
10.3 Europe
10.3.1 Germany
10.3.1.1 Increasing Prevalence of Chronic Diseases and Large-Scale Outsourcing of Clinical Diagnostic Tests By Hospitals to Commercial Service Providers to Support Market Growth
10.3.2 UK
10.3.2.1 Government Initiatives to Drive Market Growth in the UK
10.3.3 France
10.3.3.1 High Prevalence of Cancer to Support Market Growth in France
10.3.4 Italy
10.3.4.1 High Prevalence of Cancer and Increasing Per Capita Healthcare Spending to Support Market Growth in Italy
10.3.5 Spain
10.3.5.1 High Incidence of Chronic Diseases to Drive Market Growth in Spain
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.1.1 Presence of A Well-Developed Healthcare System to Support Market Growth in Japan
10.4.2 China
10.4.2.1 Rising Healthcare Expenditure to Drive the Market Growth
10.4.3 India
10.4.3.1 Growing Healthcare Sector in the Country to Drive Market Growth
10.4.4 Rest of Asia Pacific
10.5 Rest of the World
11 Competitive Landscape
11.1 Overview
11.2 Market Share Analysis, 2018
11.3 Competitive Scenario
11.3.1 Partnerships, Agreements, and Collaborations (2016-2019)
11.3.2 Product Launches (2016-2019)
11.3.3 Acquisitions (2016-2019)
11.4 Competitive Leadership Mapping (Overall Market)
11.4.1 Vendor Inclusion Criteria
11.4.2 Vanguards
11.4.3 Innovators
11.4.4 Dynamic Players
11.4.5 Emerging Players
12 Company Profiles
(Business Overview, Products Offered, Recent Developments)
12.1 Amos Scientific Pty Ltd
12.2 Danaher
12.3 Diapath S.p.A.
12.4 Histo-Line Laboratories
12.5 Jinhua YIDI Medical Appliance Co. Ltd.
12.6 MEDITE GmbH
12.7 RMC Boeckeler
12.8 Sakura Finetek
12.9 SLEE Medical GmbH
12.10 Thermo Fisher Scientific
For more information about this report visit https://www.researchandmarkets.com/r/k2io0w
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.